New MS Drug Ocrevus Wins FDA Approval
U.S. sues Teva over alleged kickbacks for multiple sclerosis drug | Reuters
Swedish Biotech Faces Another Phase III Flop in Multiple Sclerosis
New MS Drug Ocrevus Wins FDA Approval
Teva forecasts worse-than-expected 'trough year' as generics hammer MS drug Copaxone | FiercePharma
![Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)](https://mma.prnewswire.com/media/1019389/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_a_Bioequ.jpg "Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)")
Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst | FiercePharma
Better Late Than Never: Novartis, Momenta Win FDA Approval for Delayed MS Drug | BioSpace
Teva embroiled in Copaxone dosage levels dispute - Globes
Court refuses injunctions in pharma patent case
Teva must face government's kickback claims over Copaxone - judge | Reuters
Another setback for Teva's laquinimod in MS - PMLiVE
Proneuron to sue Teva for billions in Copaxone damages - Globes
Teva Found Liable for Fueling Opioid Addiction in New York - WSJ
Generic drugs giant Teva to cut workforce by more than 25%
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
Teva Pharmaceuticals - Wikipedia
Hope In A Pill
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
In blow to Teva, UK court rules in favor of Copaxone patent challenge | The Times of Israel
18. Teva Pharmaceutical Industries | FiercePharma
Teva Pharmaceutical Facing EU Antitrust Investigation Over Patent Strategy for MS Drug - IP News Shots
FDA approves first MS drug for aggressive multiple sclerosis: ocrelizumab (Ocrevus) - CBS News
FDA approves first generic version of epilepsy drug Sabril from Teva
